HLN vs. SNY
Compare and contrast key facts about Haleon plc (HLN) and Sanofi (SNY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HLN or SNY.
Correlation
The correlation between HLN and SNY is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
HLN vs. SNY - Performance Comparison
Loading data...
Key characteristics
HLN:
1.58
SNY:
0.34
HLN:
2.15
SNY:
0.84
HLN:
1.31
SNY:
1.10
HLN:
2.10
SNY:
0.51
HLN:
5.03
SNY:
1.15
HLN:
6.56%
SNY:
9.55%
HLN:
20.57%
SNY:
24.18%
HLN:
-24.83%
SNY:
-46.65%
HLN:
-0.46%
SNY:
-10.26%
Fundamentals
HLN:
$48.41B
SNY:
$126.33B
HLN:
$0.42
SNY:
$2.82
HLN:
25.57
SNY:
17.70
HLN:
3.22
SNY:
0.83
HLN:
4.31
SNY:
2.81
HLN:
2.25
SNY:
1.52
HLN:
$8.31B
SNY:
$43.77B
HLN:
$5.20B
SNY:
$31.14B
HLN:
$1.73B
SNY:
$10.09B
Returns By Period
In the year-to-date period, HLN achieves a 13.55% return, which is significantly higher than SNY's 10.56% return.
HLN
13.55%
7.68%
13.91%
32.17%
N/A
N/A
SNY
10.56%
3.54%
5.34%
8.20%
5.24%
4.20%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
HLN vs. SNY — Risk-Adjusted Performance Rank
HLN
SNY
HLN vs. SNY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Haleon plc (HLN) and Sanofi (SNY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
HLN vs. SNY - Dividend Comparison
HLN has not paid dividends to shareholders, while SNY's dividend yield for the trailing twelve months is around 4.33%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HLN Haleon plc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SNY Sanofi | 4.33% | 4.22% | 3.82% | 4.22% | 3.80% | 3.61% | 3.46% | 4.29% | 3.67% | 4.03% | 3.77% | 4.19% |
Drawdowns
HLN vs. SNY - Drawdown Comparison
The maximum HLN drawdown since its inception was -24.83%, smaller than the maximum SNY drawdown of -46.65%. Use the drawdown chart below to compare losses from any high point for HLN and SNY. For additional features, visit the drawdowns tool.
Loading data...
Volatility
HLN vs. SNY - Volatility Comparison
The current volatility for Haleon plc (HLN) is 7.21%, while Sanofi (SNY) has a volatility of 8.40%. This indicates that HLN experiences smaller price fluctuations and is considered to be less risky than SNY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
HLN vs. SNY - Financials Comparison
This section allows you to compare key financial metrics between Haleon plc and Sanofi. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HLN vs. SNY - Profitability Comparison
HLN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Haleon plc reported a gross profit of 1.65B and revenue of 2.76B. Therefore, the gross margin over that period was 59.9%.
SNY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Sanofi reported a gross profit of 7.72B and revenue of 10.61B. Therefore, the gross margin over that period was 72.8%.
HLN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Haleon plc reported an operating income of 350.00M and revenue of 2.76B, resulting in an operating margin of 12.7%.
SNY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Sanofi reported an operating income of 2.29B and revenue of 10.61B, resulting in an operating margin of 21.5%.
HLN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Haleon plc reported a net income of 231.00M and revenue of 2.76B, resulting in a net margin of 8.4%.
SNY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Sanofi reported a net income of 1.87B and revenue of 10.61B, resulting in a net margin of 17.7%.